- Home
- GCTS vs XBIT Comparison
GCTS vs XBIT Comparison
Compare GCTS & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCTS
- XBIT
- Stock Information
- Founded
- GCTS 1998
- XBIT 2005
- Country
- GCTS United States
- XBIT United States
- Employees
- GCTS N/A
- XBIT N/A
- Industry
- GCTS Blank Checks
- XBIT Pharmaceuticals and Biotechnology
- Sector
- GCTS Finance
- XBIT Health Care
- Exchange
- GCTS Nasdaq
- XBIT Nasdaq
- Market Cap
- GCTS 243.2M
- XBIT 242.2M
- IPO Year
- GCTS N/A
- XBIT 2015
- Fundamental
- Price
- GCTS $2.36
- XBIT $7.69
- Analyst Decision
- GCTS Strong Buy
- XBIT
- Analyst Count
- GCTS 1
- XBIT 0
- Target Price
- GCTS $8.00
- XBIT N/A
- AVG Volume (30 Days)
- GCTS 143.8K
- XBIT 50.6K
- Earning Date
- GCTS 11-03-2024
- XBIT 11-07-2024
- Dividend Yield
- GCTS N/A
- XBIT N/A
- EPS Growth
- GCTS N/A
- XBIT N/A
- EPS
- GCTS N/A
- XBIT N/A
- Revenue
- GCTS $13,398,000.00
- XBIT N/A
- Revenue This Year
- GCTS N/A
- XBIT N/A
- Revenue Next Year
- GCTS $574.68
- XBIT N/A
- P/E Ratio
- GCTS N/A
- XBIT N/A
- Revenue Growth
- GCTS N/A
- XBIT N/A
- 52 Week Low
- GCTS $2.35
- XBIT $3.51
- 52 Week High
- GCTS $56.00
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- GCTS 34.54
- XBIT 53.41
- Support Level
- GCTS $2.54
- XBIT $6.74
- Resistance Level
- GCTS $2.70
- XBIT $7.49
- Average True Range (ATR)
- GCTS 0.20
- XBIT 0.44
- MACD
- GCTS -0.03
- XBIT -0.01
- Stochastic Oscillator
- GCTS 0.00
- XBIT 60.38
About GCTS GCT Semiconductor Holding Inc. Common Stock
GCT Semiconductor Holding Inc. is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.